Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lasmiditan
Lasmiditan
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
Xconomy
Fri, 10/11/19 - 10:50 pm
Eli Lilly
migraines
Lasmiditan
FDA
Reyvow
Biotech Eli Lilly files for FDA approval of migraine drug lasmiditan
Fierce Biotech
Wed, 11/14/18 - 04:50 pm
Eli Lilly
migraines
FDA
Lasmiditan
Lilly's bet on pain stands out amid bare pharma pipeline
Biopharma Dive
Mon, 03/26/18 - 09:58 pm
Eli Lilly
painkillers
galcanezumab
tanezumab
Lasmiditan
Lilly's turn to pain gathers momentum
BioPharma Dive
Mon, 08/7/17 - 11:30 am
Eli Lilly
Lasmiditan
migraines
Lilly's acute migraine drug succeeds in late-stage study
Yahoo/Reuters
Fri, 08/4/17 - 11:35 am
Eli Lilly
migraines
clinical trials
Lasmiditan
Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
TheStreet.com
Wed, 01/18/17 - 10:09 am
Eli Lilly
CoLucid
M&A
migraines
Lasmiditan